Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lo Re

Showing results (131-140 of 200) with videos related to

Pageof 20
Sort By:
Pharmacoepidemiology and Drug Safety|November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and DesignJim Young, Vincent Lo Re, H Nina Kim, et al.
American Journal of Public Health|December 8, 2022
Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019Laura Hawks, Emily A Wang, Adeel A Butt, et al.
BMC Gastroenterology|April 17, 2019
Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected peopleJessie Torgersen, Kaku So-Armah, Matthew S Freiberg, et al.
Journal of Hepatology|April 10, 2014
Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionDana D Byrne, Craig W Newcomb, Dean M Carbonari, et al.
The Journal of Infectious Diseases|March 11, 2015
Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected WomenVincent Lo Re, Kenneth Lynn, Emily R Stumm, et al.
The Journal of Clinical Investigation|March 6, 2025
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intakeMehdi Farokhnia, John Tazare, Claire L Pince, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 27, 2011
FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patientsLesley S Park, Janet P Tate, Amy C Justice, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2016
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceVincent Lo Re, Charitha Gowda, Paul N Urick, et al.
Annals of Epidemiology|September 10, 2018
Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infectionChristopher T Rentsch, Emily J Cartwright, Neel R Gandhi, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
Pageof 20

Showing results (131-140 of 200) with videos related to

Sort By:
Pageof 20
Pharmacoepidemiology and Drug Safety|November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and DesignJim Young, Vincent Lo Re, H Nina Kim, et al.
American Journal of Public Health|December 8, 2022
Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019Laura Hawks, Emily A Wang, Adeel A Butt, et al.
BMC Gastroenterology|April 17, 2019
Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected peopleJessie Torgersen, Kaku So-Armah, Matthew S Freiberg, et al.
Journal of Hepatology|April 10, 2014
Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionDana D Byrne, Craig W Newcomb, Dean M Carbonari, et al.
The Journal of Infectious Diseases|March 11, 2015
Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected WomenVincent Lo Re, Kenneth Lynn, Emily R Stumm, et al.
The Journal of Clinical Investigation|March 6, 2025
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intakeMehdi Farokhnia, John Tazare, Claire L Pince, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 27, 2011
FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patientsLesley S Park, Janet P Tate, Amy C Justice, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2016
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceVincent Lo Re, Charitha Gowda, Paul N Urick, et al.
Annals of Epidemiology|September 10, 2018
Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infectionChristopher T Rentsch, Emily J Cartwright, Neel R Gandhi, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
Pageof 20